← Back to Search

Other

PENG vs FIC Nerve Blocks for Hip Fracture Pain

N/A

Recruiting

Led By Lawrence Haines, MD

Research Sponsored by Antonios Likourezos

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Isolated hip fracture, intertrocanteric or more proximal

Pain score 5 or greater on a scale of 0 to 10 just prior to nerve block placement

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 60 minutes post administration of nerve block

Awards & highlights

Study Summary

This trial will help to determine if the PENG block is non-inferior to the FIC block for pain control in patients with hip fractures.

Who is the study for?

This trial is for adults over 18 with an isolated hip fracture and a pain score of 5 or more. It's not for those with multiple injuries, communication issues about pain, pregnancy, under 18 years old, intoxication, abnormal vital signs, long-term opioid use or allergy to certain local anesthetics.Check my eligibility

What is being tested?

The study compares two types of nerve blocks in emergency department patients with hip fractures: PENG block using Bupivacaine (0.50%) and FIC block using Bupivacaine (0.25%). The goal is to see if PENG provides similar or better pain relief than FIC without opioids.See study design

What are the potential side effects?

Possible side effects include reactions at the injection site like numbness or discomfort; rare but serious risks involve nerve damage or systemic effects from the medication such as heart problems or allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a hip fracture near the top of my thigh bone.

Select...

My pain level is 5 or higher on a scale of 0 to 10 before getting a nerve block.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 60 minutes post administration of nerve block

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~60 minutes post administration of nerve block

This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes post administration of nerve block for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain Score at 30 Minutes

Secondary outcome measures

Pain Score at 60 minutes

Trial Design

2Treatment groups

Active Control

Group I: PENG BlockActive Control1 Intervention

Pericapsular Nerve Group (PENG) Block (20mL of Bupivacaine 0.50%)

Group II: Fascia Iliaca CompartmentActive Control1 Intervention

Fascial Iliaca block (FIC) (40mL of Bupivacaine 0.25%) for patients with hip fractures in the ED

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Antonios LikourezosLead Sponsor

38 Previous Clinical Trials

8,421 Total Patients Enrolled

1 Trials studying Hip Fracture

64 Patients Enrolled for Hip Fracture

Lawrence Haines, MDPrincipal InvestigatorMaimonides Medical Center

Media Library

FIC Proceedure (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05102760 — N/A

Hip Fracture Research Study Groups: PENG Block, Fascia Iliaca Compartment

Hip Fracture Clinical Trial 2023: FIC Proceedure Highlights & Side Effects. Trial Name: NCT05102760 — N/A

FIC Proceedure (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05102760 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What type of individuals is this experiment suitable for?

"This clinical trial is enrolling 80 adults, aged 18 to 110 years old, that have been rated with a pain level of 5 or more on the 0-10 scale. Additionally, these participants must be Emergency Medicine Patients suffering from an isolated hip fracture located at the intertrocanteric region or higher up their body."

Answered by AI

Does eligibility for this experiment extend beyond the age of twenty?

"The requirements for participation in this scientific study stipulate that the age range of qualified participants is between 18 and 110 years old. For minors, there are 136 trials while seniors have access to 548 different research projects."

Answered by AI

What is the current size of the participant pool for this research endeavor?

"Affirmative. According to clinicaltrials.gov, this scientific investigation is currently recruiting subjects. It was initially advertised on October 20th 2021 and the most recent data update occurred on February 2nd 2022; they are looking for 80 patients from a single medical centre."

Answered by AI

Is this research project currently recruiting participants?

"Affirmative. The details on clinicaltrials.gov reveal that this study, which was initially posted on October 20th 2021, is still accepting applications from potential participants. Currently 80 patients need to be recruited from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PENG vs. FIC Block for Hip Fracture ED Patients

Antonios Likourezos 2021. "PENG vs. FIC Block for Hip Fracture ED Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05102760.

All > Pain Management > Pain